Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Jp, Peyrat"'
1
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients
Autor: Look M, van Putten W, Duffy M, Harbeck N, Ij, Christensen, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Cg, Fred Sweep, Ulm K, Jp, Peyrat, Pm, Martin, Magdelenat H, Brünner N, Catherine Duggan, Bw, Lisboa, Po, Bendahl, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder M, Manders P, Edward Fiets W, Blankenstein M, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex L, Klijn J, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens J, Po, Bendah
Publikováno v: Thrombosis and Haemostasis, 90, 538-48
Thrombosis and Haemostasis, 90, 538-548. Georg Thieme Verlag
Europe PubMed Central
Thrombosis and Haemostasis, 90, 3, pp. 538-48
Scopus-Elsevier
Item does not contain fulltext In this report we present an extension of the pooled analysis of the prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I in breast cancer patients. We analyzed a different endpoint, m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c930058ef1b9e1daab6d7e59894e29
https://doi.org/10.1160/th02-11-0264
Zobrazit plný text záznamu
2
Age as a prognostic factor in breast cancer
Autor: LAURENCE VANLEMMENS, Hebbar M, Jp, Peyrat, Bonneterre J
Publikováno v: Europe PubMed Central
We retrospectively analysed data from 1751 patients with non-metastatic and non-inflammatory breast cancer treated in our institution between 1977 and 1989, in order to evaluate the link between age and prognosis in breast cancer. We chose three age
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50998041c60841a537bee36faa552fb0
https://pubmed.ncbi.nlm.nih.gov/9677440
Zobrazit plný text záznamu
3
[Attitudes towards screening and prevention of breast and ovarian cancers with hereditary predisposition. Survey by female gynecologists in the north of France]
Autor: Vennin P, Giard S, Julian-Reynier C, Sailly F, Jp, Peyrat, Fournier C, Francois Eisinger, Sobol H
Publikováno v: Europe PubMed Central
Search for mutations of BRCA1 in women at hereditary risk for cancer is now possible. We asked the female gynaecologists of our county (north of France) their opinion about the search of a mutation of BRCA1 if they had a familial risk of breast cance
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::11da77a5dbfb55b944a2f45b4a1651f9
https://pubmed.ncbi.nlm.nih.gov/8952643
Zobrazit plný text záznamu
5
[Immunocytochemical analysis of human prolactin receptors using anti-idiotypic antibodies in human breast cancer]
Autor: Leroy-Martin B, Jp, Peyrat, Souliman Amrani, Lorthioir M, Leonardelli J
Publikováno v: Europe PubMed Central
In this study, we have prepared antiidiotypic antibodies specific of human prolactin receptors (PRL-R) in order to localize these receptors in breast cancer. Antiidiotypic antibodies were prepared using anti-human prolactin (anti-hPRL) sera obtained
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ec14aa65a44c66a8a67181be52ab9de2
http://europepmc.org/abstract/med/7639855
Zobrazit plný text záznamu
6
[P53 antibodies: a new method for the analysis of alterations of the p53 gene: application to breast cancer]
Autor: thierry soussi, Jp, Peyrat, Lubin R, Bonneterre J
Publikováno v: Europe PubMed Central
Alterations in the p53 gene are found in 20% to 40% of breast cancers and are generally associated with factors of adverse prognostic significance. In most instances, point mutations modify the confirmation of p53, causing the gene to accumulate in t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::38284a37069eed37aa5b4753df85fb9a
http://europepmc.org/abstract/med/8763583
Zobrazit plný text záznamu
7
Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers
Autor: Jp, Peyrat, LAURENCE VANLEMMENS, Fournier J, Huet G, Révillion F, Bonneterre J
Publikováno v: Europe PubMed Central
We measured the levels of p53 and urokinase-type plasminogen activator (uPA) in 634 tumor tissues from 634 different node-negative primary breast cancer patients who underwent locoregional surgery in the Center Oscar Lambret between July 1989 and Sep
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a1b5a45c3cdbcf96fb45d3d2bbc99d0c
http://europepmc.org/abstract/med/9516970
Zobrazit plný text záznamu
8
Akademický článek
Classification of PTEN germline non-truncating variants: a new approach to interpretation.
Autor: Margot H; Medical Genetics Departement, CHU de Bordeaux, Bordeaux, Nouvelle-Aquitaine, France., Jones N; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France., Matis T; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France., Bonneau D; U771-CNRS6214, UMR INSERM, Angers, France.; School of Medicine, University of Angers, Angers, France., Busa T; Medical Genetics Departement, Marseille Public University Hospital System, Marseille, France., Bonnet F; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France., Conrad S; Medical Genetics Departement, University Hospital Centre Nantes, Nantes, Pays de la Loire, France., Crivelli L; Department of Oncogenetics, Centre Eugene Marquis, Rennes, Bretagne, France., Monin P; Medical Genetics Departement, Centre Hospitalier Universitaire de Lyon, Lyon, Rhône-Alpes, France., Fert-Ferrer S; Medical Genetics Departement, Centre Hospitalier Métropole Savoie, Chambery, France., Mortemousque I; Cancer Genetics Unit, Centre Hospitalier Régional Universitaire de Tours, Tours, Centre-Val de Loire, France., Raad S; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France., Lacombe D; Department of Medical Genetics, CHU Bordeaux GH Pellegrin, Bordeaux, Aquitaine, France.; MRGM INSERM U1211, Universite de Bordeaux College Sciences de la Sante, Bordeaux, Nouvelle-Aquitaine, France., Caux F; Hospital Avicenne Internal Medicine Service, Bobigny, Île-de-France, France., Sevenet N; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France.; UMR1312, INSERM, BoRdeaux Institute of onCology, Bordeaux, France., Bubien V; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France v.bubien@bordeaux.unicancer.fr., Longy M; Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France.; UMR1312, INSERM, BoRdeaux Institute of onCology, Bordeaux, France.
Publikováno v: Journal of medical genetics [J Med Genet] 2024 Nov 25; Vol. 61 (12), pp. 1071-1079. Date of Electronic Publication: 2024 Nov 25.
Zobrazit plný text záznamu
9
Akademický článek
IGG3 anti‐HLA donor‐specific antibodies and graft function in pediatric kidney transplant recipients.
Autor: Hamdani, Gilad1, Goebel, Jens W.2, Brailey, Paul3, Portwood, Elizabeth A.3, Hooper, David K.1 david.hooper@cchmc.org, Girnita, Alin L.3,4 girnitan@ucmail.uc.edu
Publikováno v: Pediatric Transplantation. Aug2018, Vol. 22 Issue 5, p1-1. 9p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje